Here are five takeaways:
1. The company raised $7.5 million.
2. The funds will help the company grow its core market of orthopedic and head and neck procedures and products, specifically its handheld nerve monitor device.
3. The device helps physicians avoid motor nerve damage during surgery.
4. It helps physicians gauge nerve and muscle health.
5. The device has been on the U.S. market since 2009.
More articles on devices:
Chondroitin sulfate proves effective for osteoarthritis patients — 5 findings
Alphatec’s shares dip by 4.39% — 4 points
Xtant Medical’s Aranax Cervical Plating System successfully used in 1st procedure: 5 key notes
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
